Epigenomics AG Executive Jens Ravens to Depart Company by April 30, 2024

• Jens Ravens, Executive Board member of Epigenomics AG, leaves the company on April 30, 2024
• Ravens' departure is due to the successful transfer of nearly all assets of the company to New Day Diagnostics LLC
• Ravens made significant contributions to secure the continued existence of Epigenomics AG through restructuring and asset sale
• Ravens initially served as Chief Financial Officer and later as sole member of the Executive Board
• Hansjörg Plaggemars will manage the company as sole member of the Executive Board from May 1, 2024
• Dr. Helge Lubenow thanked Ravens on behalf of the Supervisory Board for his contributions and regrets his departure.

The price of Epigenomics at the time of the news was 1,6200EUR and was up +2,53 % compared with the previous day.

Epigenomics

-3,66 %

+2,50 %

+2,82 %

-12,53 %

+166,67 %

+30,37 %

-88,88 %

-96,36 %

-83,68 %

ISIN:DE000A37FT41WKN:A37FT4

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max